AUM $86.8MER 1.19%NAV $85.11Holdings 274Inception Apr 2010
Price Chart
Key Statistics
Previous Close
$77.75Day Range
$76.85$78.11
52-Week Range
$36.99$88.85
Avg Volume
12.2KDividend Yield
0.75%Expense Ratio
1.19%AUM
$86.8MShares Outstanding
839.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 60.96% |
| Other | 31.64% |
| United Kingdom | 1.37% |
| Netherlands | 1.35% |
| France | 0.96% |
| Ireland | 0.92% |
| Denmark | 0.86% |
| Germany | 0.54% |
| Canada | 0.50% |
| Switzerland | 0.31% |
| Singapore | 0.12% |
| Bermuda | 0.11% |
| Jersey | 0.08% |
| Iceland | 0.07% |
| Spain | 0.06% |
| Cayman Islands | 0.04% |
| China | 0.04% |
| Australia | 0.04% |
| Israel | 0.03% |
| Belgium | 0.03% |
| Taiwan (Province of China) | 0.01% |
Fund Information
- Issuer
- ProShares
- Category
- Healthcare
- Inception Date
- Apr 7, 2010
- Exchange
- NASDAQ
- Description
- ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
Similar ETFs
The ProShares - Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund issued by ProShares that launched on Apr 7, 2010. It currently manages $86.8M in assets under management. The fund charges an expense ratio of 1.19%. The fund holds 274 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 61.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | Net Other Assets (Liabilities) | 29.55% | 23,944,573 | $23.9M |
| 2 | GILD | GILEAD SCIENCES INC | 6.91% | 38,798 | $5.6M |
| 3 | VRTX | VERTEX PHARMACEUTICALS INC | 6.64% | 11,259 | $5.4M |
| 4 | AMGN | AMGEN INC | 6.42% | 14,134 | $5.2M |
| 5 | REGN | REGENERON PHARMACEUTICALS | 4.27% | 4,637 | $3.5M |
| 6 | ALNY | ALNYLAM PHARMACEUTICALS INC | 2.32% | 5,931 | $1.9M |
| 7 | INSM | INSMED INC | 1.65% | 9,574 | $1.3M |
| 8 | BIIB | BIOGEN INC | 1.50% | 6,586 | $1.2M |
| 9 | UTHR | UNITED THERAPEUTICS CORP | 1.27% | 1,932 | $1.0M |
| 10 | MRNA | MODERNA INC | 1.16% | 17,539 | $936K |
| 11 | ARGX | ARGENX SE - ADR | 1.14% | 1,306 | $926K |
| 12 | ROIV | ROIVANT SCIENCES LTD | 1.10% | 31,224 | $891K |
| 13 | RPRX | ROYALTY PHARMA PLC- CL A | 1.09% | 19,183 | $880K |
| 14 | RVMD | REVOLUTION MEDICINES INC | 1.02% | 8,679 | $825K |
| 15 | INCY | INCYTE CORP | 1.00% | 8,813 | $811K |
Page 1 of 6
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.88% | |
| 1W | -2.69% | |
| 1M | -11.22% | |
| 3M | -7.29% | |
| 6M | +33.14% | |
| YTD | -0.74% | |
| 1Y | +46.89% | |
| 3Y | +49.59% | |
| 5Y | -16.20% |
Moving Averages
20-Day MA
$83.53
Below 20-Day MA50-Day MA
$84.01
Below 50-Day MA200-Day MA
$65.29
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$88.85
Current Price
$77.07
52-Week Low
$36.99
$36.99$88.85
Current Yield
0.75%
Annual Dividend
$0.6167
Frequency
4x/year
Last Ex-Date
Dec 24, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 24, 2025 | $0.1346 | Dec 31, 2025 |
| Sep 24, 2025 | $0.1805 | Sep 30, 2025 |
| Jun 25, 2025 | $0.1706 | Jul 1, 2025 |
| Mar 26, 2025 | $0.1309 | Apr 1, 2025 |
| Dec 23, 2024 | $0.3964 | Dec 31, 2024 |
| Sep 25, 2024 | $0.1528 | Oct 2, 2024 |
| Jun 26, 2024 | $0.2648 | Jul 3, 2024 |
| Mar 20, 2024 | $0.0403 | Mar 27, 2024 |
| Dec 20, 2023 | $0.0384 | Dec 28, 2023 |
| Dec 22, 2022 | $0.0199 | Dec 30, 2022 |
| Sep 21, 2010 | $0.0878 | Sep 28, 2010 |
Dividend Payments Over Time
Category Comparison
| Metric | BIB | Healthcare(222 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 1.19% | 0.59% | 0.83% |
| AUM | $86.8M | $1.25B | $1.51B |
| Dividend Yield | 0.75% | 3.21% | 1.97% |
| Avg Volume | 12.2K | 587.4K | 963.1K |
| Holdings | 274 | 172 | 66 |
| Performance | |||
| 1-Month Return | -10.68% | -5.82% | -4.61% |
| 6-Month Return | +37.22% | +5.41% | +13.21% |
| YTD Return | -2.54% | -2.61% | -3.20% |
| 1-Year Return | +46.57% | +14.91% | +21.64% |
Compare with Another ETF
Search for an ETF to compare with BIB: